Intelligence · Clinical pipeline
Oncology · Approved programs
Oncology programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Oncology Approved programs programs: NovaPharmaNews indexes 124 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- First People's Hospital 19 programs
- Disc Medicine 18 programs
- Chinese Academy of 16 programs
- George Institute for 8 programs
- Novartis India 6 programs
- Takeda 6 programs
- HOFFMANN-LA ROCHE 4 programs
- Telethon Foundation 4 programs
- Pfizer 3 programs
- AstraZeneca 2 programs
- Eli Lilly and 2 programs
- First Biotech (Australia) 2 programs
Pipeline programs
-
Shenlingcao Oral Liquid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Non-Small-Cell Lung
1 trial -
SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation
Ningbo Cancer Hospital
Gastroenteropancreatic neuroendocrine tumors
1 trial -
TAGRISSO 80 mg film-coated tablets
Disc Medicine
EGFR mutated locally advanced or metastatic non-small cell lung cancer
1 trial -
TAGRISSO 80 mg film-coated tablets
Disc Medicine
EGFR mutated locally advanced or metastatic non-small cell lung cancer
1 trial -
TAMOXIFEN
Disc Medicine
Breast cancer
1 trial -
TailorDose-II
The George Institute
Breast cancer female NOS
1 trial -
Talzenna 1 mg hard capsules
Disc Medicine
Breast cancer
1 trial -
Temozolomide
Monte Rosa Therapeutics
Brain Neoplasms, Malignant, Primary
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Tislelizumab + cisplatin + paclitaxel
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Toripalimab
Coherus Oncology
Nasopharyngeal Cancer Recurrent
1 trial -
Tramadol HCI/acetaminophen
Janssen-Cilag Pty Ltd
Cancer
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
V0001699
Disc Medicine
Oral cancer
1 trial -
Vemurafenib
Hoffmann-La Roche
Neoplasms
1 trial -
Venetoclax
AbbVie
Acute Myeloid Leukemia (AML)
1 trial -
Xiang Sha Liu Jun Zi Decoction dry powder
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
Xtandi - 40 mg soft capsules
The George Institute
PROSTATE CANCER
1 trial -
aspirin and/or clopidogrel
Takeda
Early Gastric Cancer
1 trial -
crizotinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Systemic Anaplastic Large-Cell Lymphoma
1 trial -
dabrafenib
Novartis Pharmaceuticals
Melanoma
1 trial -
docetaxel
Hoffmann-La Roche
Breast Cancer
2 trials -
first-line scheme+compound kushen injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Colorectal Carcinoma
1 trial -
inotuzumab ozogamicin-dose level 2
Pfizer
Leukemia
1 trial -
neoadjuvant therapy
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma Resectable
1 trial -
silk suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
temsirolimus
Pfizer
Non-Hodgkin's Lymphoma
1 trial -
trastuzumab [Herceptin]
Hoffmann-La Roche
Gastric Cancer
1 trial
Frequently asked questions
How many oncology Approved programs programs exist?
124 programs match both the therapeutic area and stage filters in our published index.